Anderson Cindy M, Schmella Mandy J
Cindy M. Anderson is an associate professor and an associate dean for academic affairs and educational innovation at the Ohio State University College of Nursing, Columbus, and a member of the medical advisory board of the Preeclampsia Foundation. Mandy J. Schmella is an assistant professor at the University of Pittsburgh School of Nursing, Pittsburgh, PA. Both authors contributed equally to the development of this article. Contact author: Cindy M. Anderson,
Am J Nurs. 2017 Nov;117(11):30-38. doi: 10.1097/01.NAJ.0000526722.26893.b5.
: Preeclampsia, one of four hypertensive disorders of pregnancy, has traditionally been characterized as new-onset hypertension and proteinuria developing after 20 weeks' gestation. It is, however, now understood to be a complex, progressive, multisystem disorder with a highly variable presentation and a number of potentially life-threatening complications. The American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy has refined preeclampsia diagnostic criteria accordingly, and as the disorder's pathogenesis has been more clearly defined, new targets for screening, diagnosis, prevention, and treatment have emerged. This clinical update provides a review of current practice related to preeclampsia risk assessment, prediction, and management. It discusses preeclampsia pathophysiology and points readers to valuable health care resources on the topic.
子痫前期是妊娠期四种高血压疾病之一，传统上被定义为妊娠20周后出现的新发高血压和蛋白尿。然而，现在人们认识到它是一种复杂的、进行性的多系统疾病，表现高度可变，并有许多潜在的危及生命的并发症。美国妇产科医师学会妊娠高血压特别工作组相应地完善了子痫前期的诊断标准，随着该疾病发病机制的更明确界定，筛查、诊断、预防和治疗的新靶点也已出现。本临床更新对当前子痫前期风险评估、预测和管理的相关实践进行了综述。它讨论了子痫前期的病理生理学，并为读者指出了有关该主题的宝贵医疗资源。
